Poly-D-lysine hydrobromide (MW 30000-70000)
Code | Size | Price |
---|
TAR-T40363-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T40363-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Poly-D-lysine hydrobromide (MW 30,000-70,000) is a commonly employed synthetic polymeric substrate in neural cell culture, renowned for its efficacy. This compound efficiently eliminates proteinase K-resistant PrP from prion-infected SN56 neuroblastoma cells while concurrently leaving PrP C unaffected.
CAS:
27964-99-4
Molecular Weight:
227.102
Purity:
0.98
SMILES:
Br.NCCCC[C@@H](N)C(O)=O
References
HansVermeersch, et al. Immunogenicity of poly-D-lysine, a potential polymeric drug carrier. Journal of Controlled Release. Volume 32, Issue 3, 1 December 1994, Pages 225-229.
Zhou Xu, et al. Mechanistic insights into cellular alteration of prion by poly-D-lysine: the role of H2H3 domain. FASEB J. 2011 Oct;25(10):3426-35.